Loading clinical trials...
Loading clinical trials...
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of EN3835 In The Treatment Of Edematous Fibrosclerotic Panniculopathy (Cellulite)
Conditions
Interventions
EN3835
Placebo
Locations
25
United States
Endo Clinical Trial Site #1
Glendale, Arizona, United States
Endo Clinical Trial Site #2
North Little Rock, Arkansas, United States
Endo Clinical Trial Site #3
Beverly Hills, California, United States
Endo Clinical Trial Site #4
Murrieta, California, United States
Endo Clinical Trial Site #5
Newport Beach, California, United States
Endo Clinical Trial Site #6
San Diego, California, United States
Start Date
February 8, 2018
Primary Completion Date
September 26, 2018
Completion Date
September 26, 2018
Last Updated
October 8, 2020
Lead Sponsor
Endo Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions